Cargando…

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas

Glioma is the most common malignancy of the central nervous system. Although advances in surgical resection, adjuvant radiotherapy, and chemotherapy have been achieved in the last decades, the prognosis of gliomas is still dismal. COL5A1 is one of the collagen members with minor content but prominen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Sujie, Peng, Zesheng, Wu, Yuxi, Wang, Yihao, Lei, Deqiang, Jiang, Xiaobing, Zhao, Hongyang, Fu, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635112/ https://www.ncbi.nlm.nih.gov/pubmed/34868960 http://dx.doi.org/10.3389/fonc.2021.752694

Ejemplares similares

Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma
por: Peng, Zesheng, et al.
Publicado: (2023)

The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma
por: Zhu, Jinchao, et al.
Publicado: (2022)

A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas
por: Wu, Yuxi, et al.
Publicado: (2022)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer
por: Luo, Qi, et al.
Publicado: (2022)

Circular RNA hsa_circ_0007507 May Serve as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zhang, Weiwei, et al.
Publicado: (2021)

DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker
por: Zhang, Jingwen, et al.
Publicado: (2021)

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
por: Xie, Qijun, et al.
Publicado: (2022)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)

ZCCHC17 Served as a Predictive Biomarker for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Fahui, et al.
Publicado: (2022)

CASP6 predicts poor prognosis in glioma and correlates with tumor immune microenvironment
por: Guo, Kai, et al.
Publicado: (2022)

Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas
por: Zhu, Huaxin, et al.
Publicado: (2022)

Calcium-Related Gene Signatures May Predict Prognosis and Level of Immunosuppression in Gliomas
por: Liu, Peidong, et al.
Publicado: (2022)

Quantitative study of bioinformatics analysis on glioma: a bibliometric analysis
por: Yang, Xiaobing, et al.
Publicado: (2023)

Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis
por: Zhang, Lihua, et al.
Publicado: (2020)

Neutrophilia and post-radiation thrombocytopenia predict for poor prognosis in radiation-treated glioma patients
por: Hsu, Eric J., et al.
Publicado: (2022)

Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer
por: Zhang, Jinxiu, et al.
Publicado: (2019)

COL4A1 as a novel oncogene associated with the clinical characteristics of malignancy predicts poor prognosis in glioma
por: Wang, Hongbo, et al.
Publicado: (2021)

Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients
por: Li, Xin, et al.
Publicado: (2021)

Downregulation of Brain Enriched Type 2 MAGEs Is Associated With Immune Infiltration and Poor Prognosis in Glioma
por: Arora, Mohit, et al.
Publicado: (2020)

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma
por: Xiong, Yujia, et al.
Publicado: (2021)

A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
por: Peng, Xiaojiang, et al.
Publicado: (2023)

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
por: Yang, Hai-deng, et al.
Publicado: (2023)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

COL3A1, COL5A1 and COL6A2 serve as potential molecular biomarkers for osteoarthritis based on weighted gene co‑expression network analysis bioinformatics analysis
por: Zhang, Yufeng, et al.
Publicado: (2023)

A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis
por: Li, Rongkang, et al.
Publicado: (2023)

Identifying the Hub Genes of Glioma Peritumoral Brain Edema Using Bioinformatical Methods
por: Wu, Yuxi, et al.
Publicado: (2022)

Sialidase NEU1 May Serve as a Potential Biomarker of Proliferation, Migration and Prognosis in Melanoma
por: Peng, Qiu, et al.
Publicado: (2022)

Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis
por: Zheng, Ruipan, et al.
Publicado: (2017)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification
por: Peng, Zesheng, et al.
Publicado: (2023)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
por: Ghouzlani, Amina, et al.
Publicado: (2021)

PGAM5: A necroptosis gene associated with poor tumor prognosis that promotes cutaneous melanoma progression
por: Peng, Jianzhong, et al.
Publicado: (2022)

Novel Biomarker Genes for Prognosis of Survival and Treatment of Glioma
por: Zhu, Xiaopeng, et al.
Publicado: (2021)

Tre2-Bub2-Cdc16 Family Proteins Based Nomogram Serve as a Promising Prognosis Predicting Model for Melanoma
por: Tang, Ling, et al.
Publicado: (2020)

EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis
por: Wu, Yuxi, et al.
Publicado: (2023)

A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas
por: Gao, Feng, et al.
Publicado: (2021)

Bright Edge Sign on High b-Value Diffusion-Weighted Imaging as a New Imaging Biomarker to Predict Poor Prognosis in Glioma Patients: A Retrospective Pilot Study
por: Zeng, Qiang, et al.
Publicado: (2019)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4es3meg12jc2fu27khbm9vohn7